Small Pharmaceuticals

Alembic Pharmaceuticals Ltd.

APLLTD

Market Cap
₹16,308 Cr.
P/E
23.52

Alembic Pharmaceuticals Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
16,308 Cr
PE
PE
23.52
Prom Holding
Prom Holding
69.87 %
ROE (%)
ROE (%)
11.89
ROCE (%)
ROCE (%)
14.48
Div Yield (%)
Div Yield (%)
1.45
Sales
Sales
7,783 Cr
OPM (%)
OPM (%)
15.02 %
Debt to Equity
Debt to Equity
0.24
Institutions
Institutions
20.12 %
Individual < 2 lac
Individual < 2 lac
6.52 %
No. of Shareholders
No. of Shareholders
86,796
View more
Edit Ratio's

About

Alembic Pharmaceuticals Limited, a flagship company of the Alembic Group, is engaged in manufa… Read more
Low
636
52W Range
High
1002
  • Alembic Pharma
  • Natco Pharma
  • Jubilant Pharmova
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

10 Yes

Positive for this company

0 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

1.40 %
(as of Jun 23)
Historic
Anti - Diabetes - Market Share
2.10 %
(as of Jun 23)
Historic
Anti-Infectives - Market Share
0.14 %
(as of Nov 21)
Historic
Anti-Malarial - Market Share
0.01 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.26 %
(as of Nov 21)
Historic
Blood Related - Market Share
1.80 %
(as of Jun 23)
Historic
Cardiovascular - Market Share

Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Formulations

Product Wise Break-Up - Domestic Branded Formulation Business

Location Wise Break-Up - API

Location Wise Break-Up - Formulations

Location Wise Break-Up

Therapeutic Area Break-Up

Acute vs Chronic - Formulations

Operational Metrics

    locked
    Select a Metric
    • US DMF Filings (.)
      Source
    • Number of ANDA's Filed in Europe
      Source
    • Number of ANDA's Approved in Europe
      Source
    • Number of ANDA's Filed in Canada
      Source
    • Number of ANDA's Approved by Canada
      Source
    • Number of ANDA's Filed in Australia
      Source
    • Number of ANDA's Approved by Australia
      Source
    • Number of ANDA's Filed in South Africa
      Source
    • Number of ANDA's Approved by South Africa
      Source
    • Number of ANDA's Filed in Latam
      Source
    • Number of ANDA's Approved by Latam
      Source
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Azithral
    Tellzy
    Zeet

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Shaily Engineering Plastics Ltd.
    • Aarti Drugs Ltd.
    • ICE Make Refrigeration Ltd.
    • Bharat Parenterals Ltd.
    • Take Ltd.

    FAQs on Alembic Pharmaceuticals Ltd. Business

    Alembic Pharmaceuticals Limited is a top pharmaceutical company in India known for its expertise in India Formulations, International Generics, and Active Pharmaceutical Ingredients. It excels in oncology, injectables, and ophthalmology.

    Alembic Pharma major competitors are Natco Pharma, Jubilant Pharmova, Eris Lifesciences, Caplin Point Labs., Marksans Pharma, Viyash Scientific, Astrazeneca Pharma.
    Market Cap of Alembic Pharma is ₹16,308 Crs.
    While the median market cap of its peers are ₹16,427 Crs.

    Alembic Pharma seems to be less financially stable compared to its competitors.
    Altman Z score of Alembic Pharma is 5.75 and is ranked 6 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Feb May Aug May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Feb May Aug May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Mar Jun Sep Dec Mar Jun Sep Dec Dec
    Conference Call Feb May Aug Mar Jun Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Jun Sep Dec Jun Sep Dec Jun Sep Dec Jun Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Alembic Pharmaceuticals Ltd.
    Corporate Governance Issues At Paushak - Smart Sync Services
    View the discussion on ValuePickr
    Chemicals
    A Primer On Speciality Chemicals - The Investing Hub
    Understanding The Dyes & Pigments Industry - Tycoon Mindset
    Overview of Shelf-Life Extension and Aroma Chemicals - Camlin Fine Sciences
    Flavours & Fragrances: Everything you need to know about this sector! - Anish Moonka
    Pesticides Industry Primer - ValuePickr
    Understanding the Agri-Inputs Industry - PPFAS
    Next MegaTrend in Investing : Is Methanol Next "Ethanol"? - Sadhan
    Indian agrichemical overview - a sectoral perspective - ValuePickr
    Battery Chemistry Of EV's - Value Educator
    Chemical Industry - Top Down - Capital Mind
    Chemicals Sector - Breakdown and Value Chain - PPFAS
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material